Job expired!
What if you could join an organization that creates, resources, and builds life sciences companies that invent breakthrough technologies in order to transform health care and sustainability?
Montai Health is a privately held, early-stage biotechnology company developing a platform for understanding and leveraging complex molecular interactions within organisms to solve global challenges in human health and sustainability. The company leverages a multidisciplinary approach that integrates tools ranging from machine learning and big data to multi-omics and high-throughput screening.
Montai Health was founded in Flagship's venture creation engine, where companies such as Moderna Therapeutics (NASDAQ: MRNA), Rubius Therapeutics (NASDAQ: RUBY), and Editas Medicines (NASDAQ: EDIT) were conceived and created. Since Flagship’s founding in 2000, the firm has originated and fostered the development of more than 100 scientific ventures, resulting in over $34 billion in aggregate value, 500+ issued patents, and more than 50 clinical trials for novel therapeutic agents.
At Montai, we nurture a bold, spirited and leading-edge culture dedicated to strengthening human health:
We are one team with omnidirectional trust, empowered and accountable.
We are strong as individuals but stronger as a team and we are committed to excellence.
We have a sense of urgency and persistence and we are crazily confident that we can make a difference.
We need to be comfortable with the uncomfortable and be rigorous and we recognize that failure is data.
We care for diversity in people, thought, personality, opinions, background and distinctiveness.
We have a sense of humor to help us manage through our strategic noise.
Position Summary:
We are seeking an innovative Senior Data Scientist to join Montai Health's industry-leading analytics team on the cutting edge of drug discovery. In this role, you will employ advanced analytics techniques including our proprietary CONECTA platform to generate revolutionary insights powering rapid advancement of high-potential therapeutic candidates. Collaborating cross-functionally with leadership and stakeholders, you will optimize end-to-end analytical processes and champion expanded use of predictive analytics for data-driven decision making. Your contributions will be critical as we continue pioneering new techniques that propel the discovery of life-changing therapies.
Responsibilities:
Develop and apply advanced quantitative modeling techniques to enable data-driven prioritization of Montai’s therapeutic discovery efforts.
Develop analytics pipelines leveraging compelling data visualizations to enhance communication of key quantitative insights, enabling optimization of drug development milestones.
Engage directly with scientists and senior executives to embed quantitative insights into key strategic decisions.
Champion integration of predictive analytics into high-impact nomination decisions, pipeline advancement criteria, and Go/No-Go milestone guidelines.
Assess analytical needs across drug discovery, preclinical, clinical, and CMC functions to identify high-potential use cases for advanced analytics.
Spearhead high-impact initiatives by delivering compelling proposals and prototypes that apply comprehensive analytics to propel advances in the therapeutic discovery pipeline.
Qualifications:
PhD in Computational Chemistry, Bioinformatics, Computer Science, Statistics, or related quantitative field.
5+ years experience hands-on experience in the pharmaceutical industry, leveraging predictive modeling, optimization, and other advanced analytics to accelerate development.
Cross-functional mindset and communication skills to distill analytics insights into compelling, actionable recommendations for leadership.
Superior communication skills to explain complex analytics insights and influence executive-level stakeholders.
Mastery of R and/or Python; proficiency in SQL; deep expertise in statistical analysis, data visualization, and knowledge of machine learning algorithms.
Successful track record of leveraging advanced analytics to drive innovation and accelerate therapeutic discovery timelines.
Demonstrated ability to quickly master new data science technologies and adapt analytics approaches to evolving pharmaceutical R&D needs.
Skilled at recognizing high-potential process improvements and executing analytics-powered transformations.
More About Flagship Pioneering:
Flagship Pioneering has conceived of and created companies such as Moderna Therapeutics (NASDAQ: MRNA), Editas Medicine (NASDAQ: EDIT), Omega Therapeutics (NASDAQ: OMGA), Seres Therapeutics (NASDAQ: MCRB), and Indigo Agriculture. Since its launch in 2000, Flagship has applied its unique hypothesis-driven innovation process to originate and foster more than 100 scientific ventures. In 2021, Flagship Pioneering was ranked 12th globally on Fortune’s “Change the World” list, an annual ranking of companies that have made a positive social and environmental impact through activities that are part of their core business strategies.
Flagship Pioneering and our ecosystem companies are committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or Veteran status.
Recruitment & Staffing Agencies:
Flagship Pioneering and its affiliated Flagship Lab companies (collectively, “FSP”) do not accept unsolicited resumes from any source other than candidates. The submission of unsolicited resumes by recruitment or staffing agencies to FSP or its employees is strictly prohibited unless contacted directly by Flagship Pioneering’s internal Talent Acquisition team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of FSP, and FSP will not owe any referral or other fees with respect thereto.
